Secretory immunity following mutans streptococcal infection or immunization

Area of Science:

• Immunology
• Microbiology
• Dentistry

Background:

• Salivary IgA antibody responses to mutans streptococci emerge in early childhood, preceding permanent oral biofilm colonization.
• These early immune responses target essential components for mutans streptococci establishment and emergence.
• Factors like antigen dose, immune maturity, and prior exposure to similar epitopes modulate initial responses.

Purpose of the Study:

• To investigate the role of salivary antibodies in modulating mutans streptococci infection.
• To explore the potential of experimental vaccine approaches in controlling oral biofilm-related diseases.
• To assess the efficacy of elevated oral antibody levels in preventing or mitigating infection.

Main Methods:

• Analysis of early childhood salivary IgA antibody responses to mutans streptococci.
• Evaluation of experimental vaccine approaches under controlled infection conditions.
• Review of limited clinical trials assessing active or passive immunization strategies.

Main Results:

• Elevated levels of oral antibodies, regardless of isotype or delivery method, can modify infection and disease.
• Experimental vaccine approaches have demonstrated the ability to protect against oral infections.
• Limited human clinical trials support the utility of these immunotherapeutic strategies.

Conclusions:

• Salivary antibody responses play a crucial role in managing mutans streptococci colonization and oral health.
• Active and passive immunization strategies show promise in preventing or treating oral infections.
• Further refinements in vaccine formulation, delivery, and timing could provide valuable tools for healthcare practitioners.